Daily BriefsMost Read

Most Read: Mayne Pharma, Shanghai Henlius Biotech , Hyundai Autoever , Fast Retailing, XtalPi Holdings, Carenet Inc, Palo Alto Networks, RPMGlobal Holdings Limited and more

In today’s briefing:

  • Mayne Disagrees With Cosette On MAC
  • Henlius (2696)’s Fail Sets (Another) Bad Precedent
  • [Quiddity Index Aug25] KOSPI 200 Leaderboard for Dec25 Rebal: 6 ADDs, 6 DELs, Two Recommended Trades
  • Fast Retailing (9983 JP) Tactical Outlook: Turning OVERSOLD, Potential BUY Ahead of Sep-25 Rebalance
  • QuantumPharm US$750m Lockup Expiry – Financial Investors Checked 35% of Stock into CCASS
  • CareNet (2150 JP): Kaname Capital Is Potentially a Headache for EQT
  • Copper Miners Update Post US Tariff Announcement
  • Palo Alto’s $25B CyberArk Deal: Major US and Global Index Implications Ahead
  • RPMGlobal (RUL AU) In Caterpillar’s Crosshairs
  • HEW: Policy Under Pressure


Mayne Disagrees With Cosette On MAC

By David Blennerhassett

  • As widely speculated, Cosette asserted to Mayne Pharma (MYX AU) on the 17th May a Material Adverse Change (MAC) has occurred.
  • Mayne disagrees, and views the pre-requisites for a MAC, as defined in the SID, have not been established. 
  • What now? The Scheme is not terminated. Both parties remain in consultation. If those talks are not satisfactory (say, a price reduction [my guess]), Cosette said it will walk. 

Henlius (2696)’s Fail Sets (Another) Bad Precedent

By David Blennerhassett

  • The question was asked in Henlius (2696 HK): So, When Was The Last Time A PE/VC Outfit Blocked A Deal? Well, now we have one as LVC inexplicably blocked.
  • It didn’t appear to make economic rationale for LVC to crash the party – knowing they would do so, and not bother to reduce their position accordingly.
  • In tandem with the TCM (570 HK) debacle, it sets another bad precedent for future/existing Hong Kong  events. Expect spreads for HK arbs to widen. And Henlius to crater.

[Quiddity Index Aug25] KOSPI 200 Leaderboard for Dec25 Rebal: 6 ADDs, 6 DELs, Two Recommended Trades

By Travis Lundy

  • KOSPI 200 is a Korean blue-chip index that tracks the 200 largest and most-liquid names listed in the KOSPI section of the Korea Exchange (KRX).
  • We expect up to 6 ADDs and 6 DELs for the December-2025 index rebal based on the latest available data. Same count as a month ago, but 5/12 name changes.
  • We have new charts available for all expected ADDs/DELs showing a variety of data we think worthwhile in terms of judging trade opportunity and risk. And two recommended trades.

Fast Retailing (9983 JP) Tactical Outlook: Turning OVERSOLD, Potential BUY Ahead of Sep-25 Rebalance

By Nico Rosti

  • In his recent insight, Brian Freitas stated that Fast Retailing (9983 JP)‘s CPAF will stay the same at the September 25 Nikkei 225 Index rebalance.
  • The stock is turning oversold—not yet extreme, but notable. Historically, this short-term downtrend pattern often reversed after two weeks of declines; we are now in the second consecutive week lower.
  • Monitor the 47150 support level: the stock is trading at 47810 at the moment of writing, if it goes at or below 47150 it will start to be clearly oversold.

QuantumPharm US$750m Lockup Expiry – Financial Investors Checked 35% of Stock into CCASS

By Clarence Chu

  • QuantumPharm (2228 HK) listed in Hong Kong after raising US$126m towards the bottom end of its IPO price range. Its six-month lockup will expire on 12th Dec 2024.
  • QuantumPharm is a R&D platform, utilizing quantum physics-based first-principles calculation, advanced AI, high-performance cloud computing, and scalable and standardized robotic automation to provide drug and material science R&D solutions.
  • In this note, we will talk about the lock-up dynamics and updates since our last note.

CareNet (2150 JP): Kaname Capital Is Potentially a Headache for EQT

By Arun George

  • Kaname Capital reported a 5.80% ownership ratio in Carenet Inc (2150 JP). Most of the shares were purchased on August 18 and 19, i.e., after the announcement of the offer.
  • Kaname has a recent history of agitating for a bump in the Proto Corp (4298 JP) tender offer. Kaname failed to prevent Proto from being privatised.
  • EQT will initially take a wait-and-see approach. If Kaname acquires a 10% stake, EQT will start to worry, but it has several options to respond. 

Copper Miners Update Post US Tariff Announcement

By Rikki Malik

  • While tariff headlines may dominate, accumulate the miners on weakness
  • The positive Supply and Demand drivers for copper are  still intact
  • Latest tariffs add to the continued inflationary pulse around the world

Palo Alto’s $25B CyberArk Deal: Major US and Global Index Implications Ahead

By Harry Kalfas


RPMGlobal (RUL AU) In Caterpillar’s Crosshairs

By David Blennerhassett

  • RPMGlobal Holdings Limited (RUL AU), a mining software technology provider, has entered into a trading halt ahead of a rumoured tilt from Caterpillar Inc (CAT US).
  • No price has been made public; although local media are reporting an Offer Price of $5/share, a 32.6% premium to undisturbed. 
  • Shares will be suspended until the 2nd September. Earlier this year, RPMGlobal transitioned to  a pure-play software company after offloading its advisory division.

HEW: Policy Under Pressure

By Phil Rush

  • President Trump’s attempt to fire Governor Cook, potentially gaining a supportive majority on the Fed, raises the risk that US policy overstimulates the economy.
  • Policy peers should not be pressured to mirror mistakes. The ECB faces data that keep accumulating hawkish pressures, but others are more susceptible, like the BOK.
  • Non-farm payroll data provide the last hope of blocking a Fed rate cut in September. Meanwhile, a rise in EA inflation to 2.1% should help rule out another ECB rate cut.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars